Related Experiment Video
Updated: Dec 5, 2025
Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
Published on: March 1, 2024
Sweet syndrome in severe ulcerative flare.
Ángela Martina Montero Moretón1, Luis Cabezudo Molleda2, Fernando Santos Santamarta1
1Aparato Digestivo, Complejo Asistencial Universitario de Palencia, España.
Sweet Syndrome, also known as Acute Febrile Neutrophilic Dermatosis, is an uncommon manifestation linked to inflammatory bowel disease. Effective treatment focuses on addressing the underlying condition, leading to good patient outcomes.
Area of Science:
- Dermatology
- Gastroenterology
- Pathology
Background:
- Sweet Syndrome, or Acute Febrile Neutrophilic Dermatosis, is an uncommon extraintestinal manifestation.
- It is associated with inflammatory bowel disease (IBD) and other systemic pathologies.
- Understanding its connection to IBD is crucial for comprehensive patient care.
Purpose of the Study:
- To highlight Sweet Syndrome as an extraintestinal manifestation of IBD.
- To emphasize the diagnostic criteria and treatment approach for Sweet Syndrome.
- To underscore the importance of managing the underlying disease for favorable outcomes.
Main Methods:
- Diagnosis is primarily based on anatomopathological findings.
- Clinical presentation and histopathological examination are key.
- Correlation with underlying systemic conditions is essential.
Main Results:
- Sweet Syndrome is an uncommon but significant manifestation in IBD patients.
- Histopathological analysis confirms the diagnosis.
- Treatment of the underlying disease drives the resolution of Sweet Syndrome.
Conclusions:
- Sweet Syndrome requires a high index of suspicion in IBD patients presenting with characteristic skin lesions.
- Anatomopathological diagnosis is definitive.
- Successful management hinges on effectively treating the associated inflammatory bowel disease or other underlying pathology.
More Related Videos
07:25Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
Published on: October 13, 2023
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
Related Concept Videos
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
01:24Nephrotic Syndrome I : Introduction
01:24Nephrotic Syndrome III : Nursing Management
01:26Nephrotic Syndrome II : Assessment and Medical Management
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...